As if damage to people and supply chains by the coronavirus pandemic and economic freefall weren’t bad enough, add to it the greater difficulty of monitoring human rights violations in distant farms and factories.

Moe Vela, chief transparency officer with TransparentBusiness, argues that companies can realize a number of business advantages by continuing to work from home when the pandemic subsides.

For shippers, carriers and consumers, was there ever a time when the near future seemed as uncertain as it does today?

The onset of the COVID-19 pandemic brought unprecedented disruption to drug development.

Trade consultant Nelson Balido, principal of Balido & Associates, outlines what Mexico's government must do in order for that country to become an attractive alternative for manufacturing products destined for U.S. consumers.

John Scannapieco, chair of the Global Business Team at the law firm of Baker Donelson, explains how the U.S.-China trade war, the coronavirus pandemic and global recession are causing companies to rethink the structure of their supply chains.

The coronavirus pandemic has laid bare the inadequacies of many supply chains when it comes to ensuring the safe, secure and rapid delivery of drugs and other critical supplies in a health crisis.

Why do some supply chains bounce back from disruptions more quickly than others? New research from the Association for Supply Chain Management clarifies what makes a company resilient.

Bernard Goor, senior vice president of sales with Infor, explains the concept behind the continuous supply chain, and reveals the biggest obstacles that companies face when trying to achieve that goal.